GeneralConnection.com ➔ Dictionary
Dictionary Search

therapeutics

Synonyms

Noun

1. medicine

2. medical specialty

Usage
AbbVie closes in on nearly $11bn deal for biotech Apogee Therapeutics - Financial Times
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports - Reuters
Viking Therapeutics (VKTX) Offers Potential With VK2735 Market Opportunity - Yahoo Finance
AbbVie Approaching $11 Billion Deal for Apogee Therapeutics, Report Says - Bloomberg
Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies - Fierce Biotech
Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year - The Motley Fool
Spero Therapeutics: Yesterday's Selloff On Utebzi Approval Seems Bewildering (NASDAQ:SPRO) - Seeking Alpha
China Sets Framework for Advanced Therapeutic Development - Genetic Engineering and Biotechnology News
The Utter Rampage That Sent This Biotech Flying 70% - Investor's Business Daily
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA) - Ophthalmology Times
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer - Elicio Therapeutics
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? - The Motley Fool
Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM) - PR Newswire
Seattle biotech heavy-hitters emerge from stealth with $46M for next-gen migraine treatments - GeekWire
Viking Therapeutics (VKTX) Stock Could Be 67.2% Undervalued After Analysts Back VK2735 - simplywall.st
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema - Intellia Therapeutics
How Haya Therapeutics is targeting the dark genome to treat fibrotic disease - C&EN
Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer - Business Wire
Spero Therapeutics Approaches Key FDA Decision For Tebipenem HBr In CUTIs - RTTNews
AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics - Seeking Alpha
Towards mRNA therapeutics 2.0 - Nature
cAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara - Fierce Biotech
Intellia Therapeutics (NTLA) Stock Could Be 41.2% Undervalued After Phase 3 HAE Data - simplywall.st
AbbVie (ABBV) Nears $11B Acquisition of Apogee Therapeutics (APGE) - GuruFocus
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know - Yahoo Finance
AbbVie approaching $11B deal for Apogee Therapeutics: report - Crain's Chicago Business
Why Outlook Therapeutics (OTLK) Is Up 57.1% After FDA Validates LYTENAVA Efficacy and BLA Resubmission - Yahoo Finance
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ - LENZ Therapeutics
Faeth Therapeutics (NASDAQ: SNSE) launches $150M at-the-market stock program - Stock Titan
Challenges and opportunities in RNA-centered therapeutics - Nature
Intellia Therapeutics to Report Additional Phase 3 HAELO Data for Lonvoguran Ziclumeran (lonvo-z) in Late-Breaking Oral Presentation at EAACI 2026 - Intellia Therapeutics
RA Capital Management Reduces Stake in Werewolf Therapeutics Inc - GuruFocus
Fapon Biopharma and MOTE Therapeutics to Present Dual-Platform B-Cell Immunotherapy Franchise at BIO 2026 - PR Newswire
Why CRISPR Therapeutics Stock Has Been on a Roller-Coaster Ride This Year - Yahoo Finance
LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody - Business Wire
101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease - Business Wire
CAMP4 lures 3 new hires with 39,000 stock options - Stock Titan
Lineage Cell Therapeutics (LCTX) Stock Faces Mixed Analyst Target Changes After Fresh Coverage - Yahoo Finance
Maplight Therapeutics Says Vishwas Setia Separated As CFO Effective June 18 - TradingView
MapLight Therapeutics, part of the 2025 biotech IPO class, separates from CFO - The Business Journals
Mineralys Therapeutics (MLYS) Prices $150M Public Offering of Common Stock - Yahoo Finance
Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease - GlobeNewswire
Flax Pond Capital LLC Invests $1.52 Million in Nurix Therapeutics, Inc. $NRIX - MarketBeat
CRISPR Therapeutics AG (CRSP) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Faeth Therapeutics Launches New At-the-Market Equity Program - The Globe and Mail
Outlook Therapeutics (OTLK) Stock After FDA Review Win Is The Valuation Case Already Priced In - Yahoo Finance
PTC Therapeutics (PTCT) Moves 7.2% Higher: Will This Strength Last? - Yahoo Finance
Acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business - Servier
UMMC launches new cancer biology and therapeutics program - WJTV
Vedana Therapeutics Launches as Developer of Next-Gen Migraine Therapies - Contract Pharma
Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing - Intellia Therapeutics
Why CRISPR Therapeutics Stock Is Stuck Despite Boasting the World’s First Approved CRISPR Therapy - NAI500
Skyhawk Therapeutics Announces Twelve-Month Interim Results from Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease - PR Newswire
Vera Therapeutics (VERA) Appears Attractive After Latest FDA Agreement - Yahoo Finance
How Allogene Therapeutics (ALLO) Is Expanding Its Off-the-Shelf CAR T Platform Across Cancer and Autoimmune Disease - Yahoo Finance
Viridian Therapeutics (VRDN) Stock Could Be 84.84% Below Fair Value After Institutional Buying - simplywall.st
Relmada Therapeutics (RLMD): 10 Best Growth Stocks Under $30 to Buy Now - Yahoo Finance
Aardvark Therapeutics (AARD) Faces Investor Scrutiny Amid 56% Drop On Clinical Pause For Lead Drug Candidate- HBSS - PR Newswire
Samagya Banskota: Young American Scientist developing new ways to deliver therapeutics - Scientific American
Otsuka closes $700M deal for psych drug maker Transcend - Crain's New York
Elicio Therapeutics Investigation Initiated: SueWallSt Investigates the Officers and Directors of Elicio Therapeutics (ELTX) - Morningstar
Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study - Yahoo Finance
Did Expanding ENHANZE Partnerships and Cash Generation Just Shift Halozyme Therapeutics' (HALO) Investment Narrative? - simplywall.st
Why Neumora Therapeutics (NMRA) Faces a Major Catalyst From Navacaprant’s Upcoming Depression Data - Yahoo Finance
Implantable living materials autonomously deliver therapeutics using contained engineered bacteria - Science | AAAS
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments - Sarepta Therapeutics
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema - Intellia Therapeutics
Kardigan, Clinical-Stage Precision Cardiovascular Therapeutics, Files for Nasdaq Global Market IPO - TradingView
Spero Therapeutics stock surges on FDA approval of Utebzi - Investing.com
Intellia Therapeutics (NTLA) Skyrockets 23% on Encouraging Lonvo-Z Results - Yahoo Finance
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera - investor.lilly.com
Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials - Business Wire
WHO Technical Advisory Group on therapeutics prioritization for Bundibugyo virus disease: meeting report, 20 and 26 May 2026 - World Health Organization (WHO)
Cognition Therapeutics Announces New Composition of Matter Patent, Extending Patent Protection for Lead Candidate, Zervimesine (CT1812) Through 2045 - Yahoo Finance
Intellia Therapeutics Announces First Quarter 2026 Financial Results and Business Updates - Intellia Therapeutics
Summit Therapeutics Halts US$500m Offering After Ivonescimab Trial Results - Yahoo Finance
Faeth Therapeutics Launches $150 Million ATM Stock Offering With TD Securities - TradingView
FDA accepts resubmitted BLA from Outlook Therapeutics - The Pharma Letter
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM - Intellia Therapeutics
How Definium’s US$247 Million Shelf and New Equity Grants At Definium Therapeutics (DFTX) Have Changed Its Investment Story - simplywall.st
Wet AMD eye drug LYTENAVA enters FDA review before July 29 action date - Stock Titan
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Intellia Therapeutics
Grace Therapeutics sets FDA meeting after GTx-104 CRL - Stock Titan
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Karyopharm
MPG Spin-off QLi5 receives Multi-million Euro Investment from Qurient Therapeutics - Max-Planck-Gesellschaft
Odyssey Therapeutics sees ulcerative colitis signal in Phase 2a trial - Stock Titan
Allogene Therapeutics to Announce Interim Futility Analysis Data from its Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation LBCL on Monday, April 13, 2026 - Allogene
Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month - Yahoo Finance
Corcept Therapeutics (CORT) Stock After 114% YTD Surge Is The Rally Justified - simplywall.st
Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc. - Investing News Network
Biotech Whips Violently Between Red And Green — What's Going On? - Investor's Business Daily
Grace Therapeutics (NASDAQ: GRCE) narrows 2026 loss and details FDA path for GTx-104 - Stock Titan
Opinion: A common-sense fix for New Hampshire’s Therapeutic Cannabis Program - Concord Monitor
Grace Therapeutics (Nasdaq: GRCE) faces GTx-104 FDA CRL and writes down two pipeline drugs - Stock Titan
Dianthus Therapeutics (DNTH) Stock After CAPTIVATE Results Looks Fairly Valued - simplywall.st
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia - Yahoo Finance
Odyssey Therapeutics (NASDAQ: ODTX) posts Q1 loss but raises $288.7M - Stock Titan
Foreign Language Equivalents
Foreign Language Equivalents of 'therapeutics'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
theraeutics,   theraprutics,   therapeytics,   therapeutcis,   therrapeutics,   thetapeutics,   therapeuticss,   yherapeutics,   hterapeutics,   tjerapeutics,   herapeutics,   therapeutocs,   therapeeutics,   ttherapeutics,   thherapeutics,   thrrapeutics,   therapeuyics,   therapeutiics,   terapeutics,   therapeutis,   therapetuics,   therapeutisc,   therapeutucs,   therapeutcs,   therapeurics,   therapeuttics,   thera[eutics,   threapeutics,   therapeutic,   therapeuutics,   therapeutixs,   therapetics,   therapeuticcs,   therapeuics,   theraeputics,   theraapeutics,   theeapeutics,   theerapeutics,   therappeutics,   therapeuitcs,   therapeitics,   therapeuticd,   theapeutics,   thrapeutics,   thearpeutics,   theraoeutics,   therapuetics,   thorapeutics,   therpeutics,   therapwutics,   tehrapeutics,   therapeutivs,   therspeutics,   therapeutica,   thwrapeutics,   theraputics,   tgerapeutics,   rherapeutics,   therpaeutics
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z